Clinical Trial Update: Montelukast to Treat Bronchiolitis Obliterans [Phase 2]

View source ↗

Summary

A Phase 2 trial of montelukast for bronchiolitis obliterans and chronic graft-versus-host disease has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Graft-versus-host Disease

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bronchiolitis Obliterans, Chronic Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-10-21